Virosome influenza vaccine in children

Vaccine

Volumn 20, Issue SUPPL. 5, 2002, Pages

  Herzog, Christian ^a   Metcalfe, Ian C ^a   Schaad, Urs B ^b  

^a Berna Biotech AG   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Children; Immunisation; Influenza; Virosome

Indexed keywords

HEPATITIS A VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIROSOME; VIRUS VACCINE; VIROSOME VACCINE;

CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL TRIAL; COMMON COLD; COMPARATIVE STUDY; COUGHING; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERANCE; ECCHYMOSIS; EDEMA; FATIGUE; FEVER; HEADACHE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; IRRITABILITY; MALAISE; NAUSEA; OTITIS MEDIA; PAIN; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; REVIEW; SHIVERING; SIDE EFFECT; SKIN INDURATION; SKIN MANIFESTATION; SOCIOECONOMICS; VERTIGO; VIRUS TRANSMISSION; CHILD; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; IMMUNOLOGY; RANDOMIZED CONTROLLED TRIAL;

CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RANDOMIZED CONTROLLED TRIALS; VACCINES, VIROSOME;

EID: 0037146949     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00508-X     Document Type: Short Survey

References (36)

1. Marshall B.C., Henshaw C., Evans D.A., Bleyl K., Alder S., Liou T.G. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics. 109:2002;e80. « http://www.pediatrics.org/cgi/content/full/109/5/e80 ».
2. Kingston BJ, Wright Jr CV. Influenza in the nursing home. Am. Fam. Physician 2002;65:72, 75-8.
3. Redding G., Walker R.E., Hessel C., Virant F.S., Ayars G.H., Bensch G.et al. Safety and tolerability of cold-adapted influenza vaccine in children and adolescents with asthma. J. Pediatr. Infect. Dis. 21:2002;44-48.
4. Atlanta C.D.C. Prevention and control of influenza: recommendations of the Advisory Committee on Immunisation Practices (ACIP). MMWR. 51:2002;1-31.
5. McIntosh K., Lieu L. Is it time to give influenza vaccine to healthy infants? N. Engl. J. Med. 342:2000;275-280.
6. Moreno M.V., Cabrerizo M.R., Rincon M.J., Gomez C.G., Gomez A.J. Adverse effects associated with influenza vaccine in pediatrics. Rev. Esp. Salud. Publica. 72:1998;319-329.
7. Cohen G.M., Nettleman M.D. Economic impact of influenza vaccination in pre-school children. Pediatrics. 106:2000;973-976.
8. Luce B.R., Zangwill K.M., Palmer C.S., Mendelman P.M., Yan L., Wolff M.C.et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics. 108:2001;E24.
9. Couch R.B., Keitel W.A., Cate T.R. Improvement of inactivated influenza vaccines. J. Infect. Dis. 176:1997;38-44.
10. Schmitt-Grohe S., Banzhoff A., Klaassen B., Zielen S. Safety of an influenza-split-vaccine in children. Klin. Pediatr. 213:2001;338-342.
11. Glück R., Mischler R., Finkel B., Que J.U., Scarpa B., Cryz S.J. Jr. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet. 344:1994;160-163.
12. Conne P., Gauthey L., Vernet P., Althaus B., Que J.U., Finkel B.et al. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients. Vaccine. 15:1997;1675-1679.
13. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F.et al. Influenza and the rates of hospitalisation for respiratory disease among infants and young children. N. Engl. J. Med. 342:2000;232-239.
14. Zambon M.C., Stockton J.D., Clewley J.P., Fleming D.M. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 358:2001;1410-1416.
15. Neuzil K.M., Wright P.F., Mitchell E.F., Griffin M.R. The burden of influenza illness in children with asthma and other chronic medical conditions. J. Pediatr. 137:2000;856-864.
16. Kramarz P., DeStefano F., Gargiullo P.M.et al. Does influenza vaccination prevent asthma exacerbations in children? J. Pediatr. 138:2001;306-310.
17. Hanania N., Enright P., Sockrider M.et al. The safety of inactivated influenza vaccine in adults and children with asthma. N. Engl. J. Med. 345:2001;1529-1536.
18. Smits A.J., Hak E., Stalman W.A., van Essen G.A., Hoes A.W., Verheij T.J. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol. Infect. 128:2002;205-211.
19. Zhao J., Takamurs M., Yamaoka A., Odajima Y., Iikura Y. Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. Pediatr. Allergy Immunol. 13:2002;47-50.
20. Scuffman P.A., West P.A. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine. 20:2002;2562-2578.
21. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalisations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med. 342:2000;225-231.
22. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J.et al. Burden of interpandemic influenza in children younger than 5 years: a 25 year prospective study. J. Infect. Dis. 185:2002;147-152.
23. Balter S.E., Dowell S.F. Update on acute otitis media. Curr. Opin. Infect. Dis. 13:2000;165-170.
24. Larrabee T. Prescribing practices that promote antibiotic resistance: strategies for change. J. Pediatr. Nurs. 17:2002;126-132.
25. Ware J. Rational use of antibiotics for upper respiratory infections: an evidence-based approach. Clin. Excell. Nurse Pract. 4:2000;151-157.
26. Karma P. Vaccination and otitis media. J. Otorhinolaryngol. Relat. Spec. 64:2002;80-85.
27. Greenberg D.P. Update on the development and use of viral and bacterial vaccines for the prevention of acute otitis media. Allergy Asthma Proc. 22:2001;353-357.
28. Heikkinen T., Ruuskanen O., Waris M., Ziegler T., Arola M., Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am. J. Dis. Child. 145:1991;445-448.
29. Longini I.M., Koopman J.S., Monto A.S., Fox J.P. Estimating household and community transmission parameters for influenza. Am. J. Epidemiol. 115:1982;736-751.
30. Fox J.P., Hall C.E., Cooney M.K., Fox H.M. Influenza virus infections in Seattle families, 1975-1979. Part I. Study design, methods and the occurrence of infections by time and age. Am. J. Epidemiol. 116:1982;212-227.
31. Glezen P., Denny F.W. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288:1973;498-505.
32. Longini I.M., Coopman J.S., Monto A.S., Fox J.P. Estimating household and community transmission parameters for influenza. Am. J. Epidemiol. 115:1982;736-751.
33. Wright P. Influenza in the family. N. Engl. J. Med. 343:2000;1331-1332.
34. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating school children against influenza. N. Engl. J. Med. 344:2001;889-896.
35. Schaad U.B., Bühlmann U., Burger R.et al. Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis. Antimicrob. Agent Chemother. 44:2000;1163-1167.
36. Zuccotti G.V., Cucchi C., Sala D., Giovannini M. Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children. Acta Pediatr. 91:2002;486-487.